Cargando…
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach
Autores principales: | Banerji, Aleena, Wolfson, Anna R., Wickner, Paige G., Cogan, Amelia S., McMahon, Aubree E., Saff, Rebecca, Robinson, Lacey B., Phillips, Elizabeth, Blumenthal, Kimberly G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049186/ https://www.ncbi.nlm.nih.gov/pubmed/33866033 http://dx.doi.org/10.1016/j.jaip.2021.03.053 |
Ejemplares similares
-
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing
por: Wolfson, Anna R., et al.
Publicado: (2021) -
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
por: Banerji, Aleena, et al.
Publicado: (2021) -
Reply to “PEG skin testing for COVID-19 allergy”
por: Banerji, Aleena, et al.
Publicado: (2021) -
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
por: Blumenthal, Kimberly G., et al.
Publicado: (2021) -
Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination
por: Robinson, Lacey B., et al.
Publicado: (2021)